Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Peng-Chan Lin, Yu-Min Yeh, Pei-Ying Wu, Keng-Fu Hsu, Jang-Yang Chang, Meng-Ru Shen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/275a54870fce4b7bbc1e8f3a8e04e192 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prevalence of germline pathogenic variants in 22 cancer susceptibility genes in Swedish pediatric cancer patients
por: Kristoffer von Stedingk, et al.
Publicado: (2021) -
Author Correction: Germline variants at SOHLH2 influence multiple myeloma risk
por: Laura Duran-Lozano, et al.
Publicado: (2021) -
Loss of YY1 expression predicts unfavorable prognosis in stage III colorectal cancer
por: Hyunsung Kim, et al.
Publicado: (2021) -
Germline breast cancer susceptibility genes, tumor characteristics, and survival
por: Peh Joo Ho, et al.
Publicado: (2021) -
Heterozygous APC germline mutations impart predisposition to colorectal cancer
por: Livia Preisler, et al.
Publicado: (2021)